Companies: 10,795·Total market cap: $144.5T
StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd.

SZLSFOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$630018
P/E Ratio
52W High$0.03109
52W Low$0.0005
Overview

StageZero Life Sciences Ltd.(SZLSF)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SZLSF · 截至 2026-06-15

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2022-122021-122020-122019-122018-12
Operating Activities
Net Income($11.42M)($7.48M)($6.86M)($3.48M)($3.94M)
Depreciation & Amort.$0.44M$0.51M$0.22M$0.30M$0.31M
Stock-Based Comp.$0.24M$0.39M$0.64M$0.74M$0.43M
Change in Working Capital$3.71M($0.46M)($0.08M)($0.38M)$0.34M
Net Cash from Operations($3.53M)($8.95M)($3.06M)($4.59M)($3.29M)
Investing Activities
Capital Expenditure$0.00M($0.15M)($0.07M)($0.04M)($0.00M)
Purchases of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Sales of Investments$0.00M$0.00M$0.00M$0.00M$0.00M
Net Cash from Investing$0.00M($0.02M)($0.07M)($0.03M)($0.00M)
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$0.29M($0.39M)$0.52M$0.65M$1.39M
Net Cash from Financing$1.83M$4.10M$9.66M$4.59M$3.36M
Free Cash Flow
Free Cash Flow($3.53M)($9.10M)($3.14M)($4.64M)($3.29M)
FCF Margin %(computed)-92.98%-179.61%-75.55%

数据来源:Financial Modeling Prep · 最后更新:2026-06-15 · USD · M

深入了解StageZero Life Sciences Ltd.

关于StageZero Life Sciences Ltd.(SZLSF)现金流量表

StageZero Life Sciences Ltd. 2022财年经营活动现金流($0.00B),自由现金流($0.00B)(FCF利润率-92.98%),资本支出$0.00B。

常见问题

SZLSF · 4 问

StageZero Life Sciences Ltd. 2022财年自由现金流($0.00B),同比up61.2%。

SZLSF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15